EUVIMEDEUVIMED entdecken
Crossref

Outcomes of Transcatheter Mitral Valve Implantation for Failed Bioprostheses and Annuloplasty Rings

Chong Bin Lee iD, Victor Schweiger iD, Daniel Schwarzkopf, Marian Kukucka iD, Joerg Kempfert, Volkmar Falk iD, Henryk Dreger iD, Christoph Klein, Hristian Hinkov iD, Axel Unbehaun iD

European Journal of Cardio-Thoracic Surgery · 2026

DOI: 10.1093/ejcts/ezag031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2026. Verfasst von Chong Bin Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité (DHZC), Berlin 13353, Germany. Hauptthemen laut MEDLINE: Transcatheter Mitral Valve Replacement, Bioprosthesis, Heart Valve Prosthesis, Mitral Valve. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Transcatheter mitral valve implantation (TMVI) is increasingly used in failed bioprostheses and annuloplasty rings as a less invasive alternative to redo-surgery in selected patients, with promising results. This retrospective single-centre study aims to provide additional insight into clinical outcomes and its determinants following TMVI.

Methods

Data of all TMVI procedures (n = 88) performed between February 2014 and June 2024 were retrospectively analysed. The primary end-points were 1-year mortality and the Mitral Valve Academic Research Consortium (MVARC) composite end-points. Secondary outcomes included complications and echocardiographic outcomes.

Results

Overall, in-hospital, 30-day, and 1-year mortality rates were 6.8%, 5.8%, and 16.5%, respectively. No significant differences were observed between transseptal and transapical approach (20.0 vs 13.2%, P = .439) or between valve-in-valve and valve-in-ring procedure (16.3 vs 18.2%, P = .828). At 1-year follow-up, only one patient presented with mitral regurgitation ≥ grade 2. However, a post-procedural mean pressure gradient (MPG) ≥5 mm Hg was observed in 51 patients (58%). In multivariate analysis, higher post-procedural MPG was associated with increased mortality risk (P = .047; hazard ratio [HR] = 1.23; 95% CI, 1.00-1.51), whereas technical success was associated with reduced mortality risk (P = .014; HR = 0.12; 95% CI, 0.02-0.65).

Conclusions

Transcatheter mitral valve implantation provided acceptable mid-term mortality irrespective of procedure type and access route, with excellent technical success. Furthermore, mid-term follow-up showed near-complete elimination of mitral regurgitation. However, a high rate of post-procedural relevant mitral stenosis was observed, which may have an impact on mortality. In the light of the anticipated increase in TMVI procedures, we advocate for larger prospective studies to investigate the long-term determinants of mortality. Clinical trial registration As this study was retrospective and based on previously collected clinical data, clinical trial registration was not required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Mitral Valve ReplacementBioprosthesisHeart Valve ProsthesisMitral ValveMitral Valve AnnuloplastyHumansRetrospective StudiesFemaleProsthesis FailureMaleAgedAged, 80 and overTreatment OutcomeMitral Valve InsufficiencyReoperation

Stichwörter der Autor:innen

mitral valve diseasesurgical mitral valve replacementtranscatheter mitral valve implantation

Autor:innen und Institutionen

  • Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité (DHZC), Berlin 13353, Germany.
  • Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin 10117, Germany.
  • Deutsches Herzzentrum der Charité, Structural Heart Interventions Program (SHIP), Berlin 13353, Germany.
  • DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin 10785, Germany.
  • Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin 13353, Germany.
  • Department of Cardiac Anaesthesiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité (DHZC), Berlin 13353, Germany.

ORCID-Profile: Chong Bin Lee, Victor Schweiger, Marian Kukucka, Volkmar Falk, Henryk Dreger, Hristian Hinkov, Axel Unbehaun

Zitieren

APA

Lee, C. B., Schweiger, V., Schwarzkopf, D., Kukucka, M., Kempfert, J., Falk, V., Dreger, H., Klein, C., Hinkov, H., & Unbehaun, A. (2026). Outcomes of Transcatheter Mitral Valve Implantation for Failed Bioprostheses and Annuloplasty Rings. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezag031

Vancouver

Lee CB, Schweiger V, Schwarzkopf D, Kukucka M, Kempfert J, Falk V, et al. Outcomes of Transcatheter Mitral Valve Implantation for Failed Bioprostheses and Annuloplasty Rings. European Journal of Cardio-Thoracic Surgery. 2026. doi:10.1093/ejcts/ezag031

BibTeX
@article{Lee2026,
  author = {Lee, Chong Bin and Schweiger, Victor and Schwarzkopf, Daniel and Kukucka, Marian and Kempfert, Joerg and Falk, Volkmar and Dreger, Henryk and Klein, Christoph and Hinkov, Hristian and Unbehaun, Axel},
  title = {Outcomes of Transcatheter Mitral Valve Implantation for Failed Bioprostheses and Annuloplasty Rings},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2026},
  doi = {10.1093/ejcts/ezag031}
}
Kostenlos starten →